Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Marisa B, Schauerhamer"'
Autor:
Jerzy E. Tyczynski, Lia Gutierrez, Rishi Deka, Amy Sainski, Junjie Ma, Tapashi Dalvi, David D. Stenehjem, Casey R. Tak, Marisa B. Schauerhamer, Claire Telford, Joseph Biskupiak, James A. Kaye, Sudhir Unni, Diana I. Brixner, Hillevi Bauer, Xiangyang Ye
Publikováno v:
Breast Cancer Research and Treatment. 186:839-850
Germline BRCA mutations (BRCAm) strongly influence the risk of developing breast cancer. This study aimed to understand the role of BRCAm testing in affected individuals and to assess its impact on the outcome of BRCAm carriers compared to non-carrie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24d9cd4568eaf6f4d1dfff6318c4c3b1
https://doi.org/10.1007/s10549-020-06038-x
https://doi.org/10.1007/s10549-020-06038-x
Autor:
David D, Stenehjem, Claire, Telford, Sudhir K, Unni, Hillevi, Bauer, Amy, Sainski, Rishi, Deka, Marisa B, Schauerhamer, Xiangyang, Ye, Casey R, Tak, Junjie, Ma, Tapashi B, Dalvi, Lia, Gutierrez, James A, Kaye, Jerzy E, Tyczynski, Diana I, Brixner, Joseph E, Biskupiak
Publikováno v:
Breast cancer research and treatment. 186(3)
Germline BRCA mutations (BRCAm) strongly influence the risk of developing breast cancer. This study aimed to understand the role of BRCAm testing in affected individuals and to assess its impact on the outcome of BRCAm carriers compared to non-carrie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8f45000659d91957201e3f7c35934b58
https://pubmed.ncbi.nlm.nih.gov/33389410
https://pubmed.ncbi.nlm.nih.gov/33389410
Autor:
Eric Wittbrodt, Marisa B. Schauerhamer, Sudhir Unni, Junjie Ma, Natalia Ruiz-Negrón, Jeff Hurd, Carrie McAdam-Marx
Publikováno v:
Diabetes, Obesity and Metabolism. 20:468-473
A retrospective cohort study was conducted in patients with type 2 diabetes in an electronic medical record database to compare real-world, 6-month glycated haemoglobin (HbA1c) and weight outcomes for exenatide once weekly with those for dulaglutide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::122211ccb45ee947fd760b1e376c0208
https://doi.org/10.1111/dom.13107
https://doi.org/10.1111/dom.13107
Autor:
Sudhir Unni, Carrie McAdam-Marx, Xiangyang Ye, Marisa B. Schauerhamer, Hiep Nguyen, Mukul Singhal, David Cobden
Publikováno v:
Clinical Therapeutics. 38:2642-2651
Purpose Data comparing real-world effectiveness of the glucagon-like peptide-1 receptor agonists (GLP-1RAs) exenatide once weekly (QW) and liraglutide in the treatment of type 2 diabetes (T2D) are limited. Furthermore, there is limited information on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce28e264482a7204975490b121032572
https://doi.org/10.1016/j.clinthera.2016.11.003
https://doi.org/10.1016/j.clinthera.2016.11.003
Publikováno v:
Expert Review of Cardiovascular Therapy. 13:611-626
Type 2 diabetes mellitus is a progressive disease that requires pharmacologic treatment to prevent microvascular and macrovascular complications. As the disease progresses, most patients require combination therapy to achieve glucose control targets.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8ca0c9898544e0c1a172abb383fa6e1
https://doi.org/10.1586/14779072.2015.1038242
https://doi.org/10.1586/14779072.2015.1038242
Impact of statin guidelines on statin utilization and costs in an employer-based primary care clinic
Publikováno v:
The American journal of managed care. 23(12)
The purpose of this study was to describe statin utilization and costs in an employer-based patient cohort by comparing actual practice and assumed adoption of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) or 2016 US Pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::831d6f690a6948a3afc143b774d92fbb
https://pubmed.ncbi.nlm.nih.gov/29261246
https://pubmed.ncbi.nlm.nih.gov/29261246
Autor:
Hiep Nguyen, Marisa B. Schauerhamer, Carrie McAdam-Marx, Jeff Hurd, Sudhir Unni, Mukul Singhal
Publikováno v:
Journal of managed carespecialty pharmacy. 23(3)
Glucagon-like peptide 1 receptor agonists (GLP-1RAs) are recommended as add-on therapy in patients with uncontrolled type 2 diabetes (T2D), with no specific guidance as to timing versus insulin. Furthermore, real-world data assessing GLP-1RA outcomes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d56f093c6ea0f29cc0c94f2f4517c4e
https://pubmed.ncbi.nlm.nih.gov/28230449
https://pubmed.ncbi.nlm.nih.gov/28230449
Publikováno v:
Therapeutics and Clinical Risk Management
Diabetes mellitus is a world-wide epidemic with many long-term complications, with neuropathy being the most common. In particular, diabetic peripheral neuropathic pain (DPNP), can be one of the most distressing complications associated with diabetes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e02e138c8b0f10dd35686659eba89d9
https://doi.org/10.2147/tcrm.s74165
https://doi.org/10.2147/tcrm.s74165
Autor:
Jerzy E. Tyczynski, Claire Telford, Amy Sainski, Lia Gutierrez, Joseph Biskupiak, Diana I. Brixner, David D. Stenehjem, Rishi Deka, Hillevi Bauer, Marisa B. Schauerhamer, Sudhir Unni, James A. Kaye
Publikováno v:
Journal of Clinical Oncology. 33:e12518-e12518
e12518 Background: BRCAm are implicated in 5% of BC. Since PARP inhibitors may be preferentially active in BRCAm carriers with BC, we evaluated historical BRCAm testing patterns, clinical character...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f35430ae9ef22730fe116719b856546
https://doi.org/10.1200/jco.2015.33.15_suppl.e12518
https://doi.org/10.1200/jco.2015.33.15_suppl.e12518
Autor:
Carrie McAdam-Marx, Sudhir Unni, David Cobden, Hiep Nguyen, Mukul Singhal, Marisa B. Schauerhamer
Publikováno v:
Value in Health. 18:A54
• In patients with diabetes, poor glycemic control is associated with increased morbidity, mortality, and health care costs.1,2,3 • GLP-1 receptor agonists (GLP-1RA) have been shown to reduce HbA1c in patients with uncontrolled type 2 diabetes me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b7b25d62db9af0a1006d2b3be88f213
https://doi.org/10.1016/j.jval.2015.03.317
https://doi.org/10.1016/j.jval.2015.03.317